Strategic alliance with GlaxoSmithKline in infectious disease drug discovery

GlaxoSmithKline and Galapagos enter strategic alliance to develop novel antibacterials and antivirals

GlaxoSmithKline en Galapagos gaan strategische alliantie aan voor nieuwe antibiotica en antivirale middelen

View webcast presentation

View presentation in PDF format

Galapagos corporate factsheet (in English)

Galapagos corporate factsheet (in Dutch)


For more information, please contact the Investor Relations team at ir@glpg.com
or Marjolijn Ham at +31 71 750 6705.